Dysplastic urothelial changes accompany empagliflozin administration in urinary bladder of experimental diabetes (Q89627944)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32040227 AND SRC:MED&resulttype=core&format=json

7 April 2020

title

Dysplastic urothelial changes accompany empagliflozin administration in urinary bladder of experimental diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32040227 AND SRC:MED&resulttype=core&format=json

7 April 2020

1 reference

Ahmed A M Abdel-Hamid

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32040227 AND SRC:MED&resulttype=core&format=json

7 April 2020

author name string

Alaa El-Din L Firgany

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32040227 AND SRC:MED&resulttype=core&format=json

7 April 2020

publication date

1 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32040227 AND SRC:MED&resulttype=core&format=json

International Journal of Experimental Pathology

7 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32040227 AND SRC:MED&resulttype=core&format=json

7 April 2020

volume

100

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32040227 AND SRC:MED&resulttype=core&format=json

7 April 2020

issue

5-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32040227 AND SRC:MED&resulttype=core&format=json

7 April 2020

page(s)

369-377

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32040227 AND SRC:MED&resulttype=core&format=json

Distribution of cytokeratin polypeptides in human transitional cell carcinomas, with special emphasis on changing expression patterns during tumor progression

7 April 2020

cites work

1 reference

12 December 2020

Cytokeratin 20 as an objective marker of urothelial dysplasia.

1 reference

12 December 2020

Flat intraepithelial lesions of the urinary bladder

1 reference

12 December 2020

Intraepithelial lesions of urinary bladder: morphologic considerations

1 reference

12 December 2020

Brenner tumors but not transitional cell carcinomas of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins

1 reference

12 December 2020

Cytokeratin 7 and cytokeratin 20 in primary urinary bladder carcinoma and matched lymph node metastasis

1 reference

12 December 2020

Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non-neoplastic urothelium: an analysis of cytokeratin 20, p53, and CD44 antigens

1 reference

12 December 2020

Preneoplastic non-papillary lesions and conditions of the urinary bladder: an update based on the Ancona International Consultation

1 reference

12 December 2020

p53 protein and Ki-67 overexpression in urothelial dysplasia of bladder

1 reference

12 December 2020

Immunohistochemical expression of CK20, p53, and Ki-67 as objective markers of urothelial dysplasia.

1 reference

12 December 2020

Keratin expression profiling of transitional epithelium in the painful bladder syndrome/interstitial cystitis

1 reference

12 December 2020

The control of tissue architecture over nuclear organization is crucial for epithelial cell fate

1 reference

12 December 2020

Morphological classification and definition of benign, preneoplastic and non-invasive neoplastic lesions of the urinary bladder

1 reference

12 December 2020

Urinary tract infections and reduced risk of bladder cancer in Los Angeles

1 reference

12 December 2020

Staining patterns of keratins in the human urinary tract

1 reference

12 December 2020

Urothelial dysplasia and other flat lesions of the urinary bladder: clinicopathologic and molecular features

1 reference

12 December 2020

Diabetes mellitus and risk of bladder cancer: a meta-analysis of cohort studies

1 reference

12 December 2020

Diabetes mellitus increases the risk of bladder cancer: an updated meta-analysis

1 reference

12 December 2020

Risk of bladder cancer in patients with diabetes mellitus: an updated meta-analysis of 36 observational studies

1 reference

12 December 2020

The kidney as a new target for antidiabetic drugs: SGLT2 inhibitors

1 reference

12 December 2020

Diabetes mellitus increases the risk of bladder cancer: an updated meta-analysis of observational studies

1 reference

12 December 2020

Urothelial dysplasia of the bladder: diagnostic features and clinical significance

1 reference

12 December 2020

Carcinogenicity risk assessment supports the chronic safety of dapagliflozin, an inhibitor of sodium-glucose co-transporter 2, in the treatment of type 2 diabetes mellitus

1 reference

12 December 2020

A Review on the Relationship between SGLT2 Inhibitors and Cancer.

1 reference

12 December 2020

Nonclinical safety of the sodium-glucose cotransporter 2 inhibitor empagliflozin

1 reference

12 December 2020

Sex-, Species-, and Tissue-Specific Metabolism of Empagliflozin in Male Mouse Kidney Forms an Unstable Hemiacetal Metabolite (M466/2) That Degrades to 4-Hydroxycrotonaldehyde, a Reactive and Cytotoxic Species

1 reference

12 December 2020

Effect of testosterone therapy on the urinary bladder in experimental hypogonadism of rats

1 reference

12 December 2020

Dysplasia and carcinoma in situ of the urinary bladder

1 reference

12 December 2020

Functional expression of sodium-glucose transporters in cancer

1 reference

12 December 2020

Tubal cytokine changes accompany the epithelial atypia of letrozole-stimulated ovaries.

1 reference

12 December 2020

Hydroxychloroquine hindering of diabetic isletopathy carries its signature on the inflammatory cytokines.

1 reference

12 December 2020

Empagliflozin for Type 2 Diabetes Mellitus: An Overview of Phase 3 Clinical Trials

1 reference

12 December 2020

Favorable outcomes of hydroxychloroquine in insulin resistance may be accomplished by adjustment of the endothelial dysfunction as well as the skewed balance of adipokines

1 reference

12 December 2020

Update review of the safety of sodium-glucose cotransporter 2 inhibitors for the treatment of patients with type 2 diabetes mellitus

1 reference

12 December 2020

Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?

1 reference

12 December 2020

Reversal of tubo-ovarian atypical epithelial patterns after cessation of ovarian stimulation by letrozole

1 reference

12 December 2020

Increased Proliferative Activity Accompanies the Local Inflammatory Response of Gastric Mucosa After Intragastric Balloon Insertion

1 reference

12 December 2020

Vascular and cellular changes accompany altered expression of angiopoietins in placenta of non-complicated ART pregnancies.

1 reference

12 December 2020

Association of body mass index with bladder cancer risk: a dose-response meta-analysis of prospective cohort studies

1 reference

12 December 2020

Epidemiology of urothelial carcinoma

1 reference

12 December 2020

SGLT2 inhibitors and risk of cancer in type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials

1 reference

12 December 2020

Renal tubular and adrenal medullary tumors in the 2-year rat study with canagliflozin confirmed to be secondary to carbohydrate (glucose) malabsorption in the 15-month mechanistic rat study

1 reference

12 December 2020

A Predominant Oxidative Renal Metabolite of Empagliflozin in Male Mice Is Cytotoxic in Mouse Renal Tubular Cells but not Genotoxic.

1 reference

12 December 2020

Positron emission tomography of sodium glucose cotransport activity in high grade astrocytomas.

1 reference

12 December 2020

Empagliflozin reduces cardiovascular events, mortality and renal events in participants with type 2 diabetes after coronary artery bypass graft surgery: subanalysis of the EMPA-REG OUTCOME® randomised trial

1 reference

12 December 2020

Pathogenesis of Renal Injury and Gene Expression Changes in the Male CD-1 Mouse Associated with Exposure to Empagliflozin

1 reference

12 December 2020

Correlation between pancreatic mast cells and the low grade inflammation in adipose tissue of experimental prediabetes

1 reference

12 December 2020

Empagliflozin and kidney outcomes in Asian patients with type 2 diabetes and established cardiovascular disease: results from the EMPA-REG OUTCOME trial

1 reference

12 December 2020

A study in a rat initiation-promotion bladder tumour model demonstrated no promoter/progressor potential of dapagliflozin

1 reference

12 December 2020

Sodium-glucose cotransporters: new targets of cancer therapy?

1 reference

12 December 2020

Increased mast cell number is associated with a decrease in beta-cell mass and regeneration in type 2 diabetic rats

1 reference

12 December 2020

Effects of sodium-glucose cotransporter-2 inhibitors on the cardiovascular and renal complications of type 2 diabetes

1 reference

12 December 2020

The Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors: Beyond the Glycemic Benefit

1 reference

12 December 2020